Kairos Pharma, Ltd
Price
FilingsNewest: 8-K, Other eventsOct 6 →InsidersNo open-market buys or sales.→HoldersCitadel 1.4%Vanguard 1.1%Geode 0.4%→Financing →PeersClosest companies: RVMD, CMPX, PRLD→
From the filings
Figures
- Net income
- −$5.8Mlast 12 months
- Operating cash flow
- −$3.8Mlast 12 months
- Cash and equivalents
- $2.6Mat the last balance sheet
- Shares outstanding
- 21.4M shareson issue